NCIt definition : A preparation of autologous T-lymphocytes genetically modified to express a chimeric
antigen receptor (CAR) comprised of a CD28 co-stimulatory signaling domain fused to
the zeta chain of the TCR/CD3 complex (CD3zeta) and coupled to chlorotoxin (CLTX),
a 36-amino acid peptide derived from the venom of the deathstalker scorpion, with
potential immunomodulating and antineoplastic activities. Upon administration of autologous
CLTX-targeted CAR T-lymphocytes CHM 1101, the CAR-T cells are re-directed to specific
brain tumor cells through its tumor-targeting domain CLTX. CLTX targets and binds
to the membrane-bound endopeptidase matrix metalloproteinase-2 (MMP-2), thereby inducing
selective toxicity in MMP-2-expressing tumor cells. MMP-2 is specifically upregulated
in gliomas and related cancers, but is not normally expressed in the brain.;